Hugh Wolfenden

Royal Prince Alfred Hospital, Prince of Wales Hospital

Papers

Total Citations

H-Index

About

Hugh Wolfenden is a leading figure in cardiac surgery, with a focused expertise in minimally invasive mitral valve repair and the comparative effectiveness of robotic versus conventional surgical techniques. His major contribution lies in pioneering evidence-based evaluations of robotic surgery’s safety and efficacy, most notably through his landmark 2015 meta-analysis—cited 53 times—which systematically compared outcomes for degenerative mitral valve disease. This work provided crucial, data-driven insights that helped shape clinical decision-making and patient selection for robotic procedures. Wolfenden’s research directly addresses the pressing question of whether robotic operations are safe for mitral valve repair, offering rigorous analysis that balances innovation with patient safety. His scholarship has informed surgical protocols and training, bridging the gap between emerging technology and established practice. By synthesizing global evidence, Wolfenden has advanced the field’s understanding of robotic surgery’s role, making him a trusted voice in the ongoing evolution of cardiac surgical care.